Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Baiyang Pharmaceutical Group Investments

Profile and portfolio

Parent Baiyang PharmaceuticalHQ Qingdao, China

Baiyang Pharmaceutical Group Investments is the corporate venture arm of Baiyang Pharmaceutical, a pharmaceutical and biotech company. It is based in Qingdao, China. It invests at the growth stage. Sectors it names: healthcare and digital health, biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Growth to Growth
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeGrowth to Growth
SectorsHealthcare and digital health, Biotech and life sciences
GeographyNorth America, Asia

Sources: S1 Securities Daily: Baiyang Pharmaceutical H1 2025 results and innovation investments (2025-08-28).

Graphic 1 of 1

Investment stage: Growth to Growth

Sources: S1 Securities Daily: Baiyang Pharmaceutical H1 2025 results and innovation investments (2025-08-28).

Download:Report a correction

Where it invests

Geography

Headquarters
Qingdao, China

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyBaiyang PharmaceuticalSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
HeadquartersQingdao, ChinaSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesGrowth (inferred from announced rounds)EstimateS1

Portfolio

Public sources name 3 portfolio companies.S1

Every company on the Baiyang Pharmaceutical Group Investments list

3 companies, as named in the sources cited.S1 Read the firm's list.

  • ZAP Surgical
  • 北海康成
  • 华昊中天

Sources

  1. S1Securities Daily: Baiyang Pharmaceutical H1 2025 results and innovation investments (2025-08-28)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Baiyang Pharmaceutical Group Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.